Contents

Search

voxilaprevir

Indications: - used in combination with sofosbuvir & velpatasvir for treatment of hepatitis C genotypes 1-6 without cirrhosis

General

antiviral agent

Database Correlations

PUBCHEM cid=89921642

References

  1. FDA News Release. July 18, 2017 FDA approves Vosevi for Hepatitis C https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm567467.htm

Component-of

sofosbuvir/velpatasvir/voxilaprevir (Vosevi)